Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

Abroad (travel likely)RecruitingPHASE2

Conditions

Brain Metastases · Cancer (With CNS Involvement)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
Contact: Study coordinator (HCC Clinical Trials Office) · hcc-clinical-trials@musc.edu · 843-792-9321

Study leads

Charlotte Rivers, MD
Principal Investigator
Medical University of South Carolina

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Brain Metastases · Nsclc

Abroad (travel likely)Recruiting

Heidelberg, Germany

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Brain Metastases · Nonsmall Cell Lung Cancer Stage III

Abroad (travel likely)RecruitingPHASE2

Winston-Salem, United States

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Melanoma · Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Tianjin, China